- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Clinical Trial
Clinical Trial Search
Trial Protocol ID USOR 22272_KRT-232-118 | GOG 3089
Trial Description
A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects with TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy (KRT-232-118)
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724
Investigator
- Vinni Juneja, M.D.
Disease Types
Sponsors
- GOG Foundation
- Kartos Therapeutics
ClinicalTrials.gov NCT ID
- NCT05797831